China Pharma Holdings, Inc.
CPHI
Last
$0.86
Day
-10.7%
1y
-51.7%
5y
-96.4%
52w
-95.0%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1131d
EMA 21
0.78
EMA 50
0.86
EMA 200
1.02
20d high
-25.0%
5y high
-98.4%
5y range
1th
Positions held
Your positionsCPHI isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
20
Hold
swing
Signal
Buy
Target
$1.25
Stop
$0.72
Stop distance
16.0%
Target vs last
+45.9%
Fundamentals
| Market cap | $41.30M | Enterprise value | $45.05M | Trailing P/E | — | Forward P/E | — |
| PEG | 0.16 | Price / book | 1.08 | Beta | 1.05 | Dividend yield | 0.00% |
| Revenue growth | -7.5% | Earnings growth | — | Gross margin | 11.8% | Operating margin | -1.5% |
| Profit margin | -114.3% | ROE | -21.0% | ROA | -9.4% | Debt / equity | 0.11 |
| Current ratio | 0.26 | Free cash flow | $1.11M | Analyst recommendation | none | Mean target | — |
| 52w high | $19.19 | 52w low | $0.38 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.9M | $1.0M | $1.2M | $0.8M | $1.0M | — |
| Op margin | -151.0% | -113.6% | -97.9% | -83.0% | -48.9% | — |
| Net income | -$1.5M | -$1.1M | -$1.2M | -$0.7M | -$0.5M | — |
| Gross margin | 8.8% | 29.0% | 12.3% | -7.9% | -8.5% | — |
| Gross profit | $0.1M | $0.3M | $0.2M | -$0.1M | -$0.1M | — |
| Operating income | -$1.4M | -$1.1M | -$1.2M | -$0.6M | -$0.5M | — |
- Revenue -4% vs prior quarter ($0.9M vs $1.0M).
- Gross margin 8.8% (was 29% prior quarter).
- Operating margin compressed to -151%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $4.1M | $4.5M | $7.0M | $8.1M |
| Op margin | -74.5% | -101.2% | -39.5% | -45.0% |
| Net income | -$3.2M | -$4.7M | -$3.1M | -$4.0M |
| Gross margin | -3.2% | -43.8% | -4.0% | -6.1% |
| Gross profit | -$0.1M | -$2.0M | -$0.3M | -$0.5M |
| Operating income | -$3.1M | -$4.6M | -$2.8M | -$3.6M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-07-23 · China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering
2026-07-22 · China Pharma Announces Pricing of $5 Million Registered Direct Offering
2026-07-21 · China Pharma Holdings, Inc. Comments on Unusual Market Activity
2026-07-15 · China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity
Price (daily)
Full chart · RSI · MACD · patternsCPHI · daily+43.3% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin